InvestorsHub Logo
Followers 1
Posts 65
Boards Moderated 0
Alias Born 12/17/2013

Re: jurisper post# 2978

Wednesday, 07/09/2014 8:44:09 AM

Wednesday, July 09, 2014 8:44:09 AM

Post# of 6476
It amazes me that you think a company with license deals with two well known Universities and are also listed as applicants on patents with both Universities as a--scam. The difference with you and I is, I think survival and you think--scam!!

As you see in this article VG's science is recognized with other well known companies. There are about 150 companies mentioned and about half are Pharmaceutical and Biotechnology Companies. So how did VG's science get recognized, unless it really has potential!

https://ca.finance.yahoo.com/news/synthetic-biology-global-markets-120000530.html

NEW YORK, July 7, 2014

Synthetic Biology : Global Markets

Synthetic biology is an emerging biotechnology discipline with a wide range of applications.

The global synthetic biology market reached nearly $2.1 billion in 2012 and $2.7 billion in 2013. This market is expected to grow to $11.8 billion in 2018 with a compound annual growth rate (CAGR) of 34.4% over the five-year period from 2013 to 2018.

We have compiled a study of existing and future synthetic biology products and technologies that will be commercially important in the main end–user segments of life
science research, pharmaceuticals, diagnostics, energy, chemicals, and agriculture.

MERCK & CO. 238

PFIZER 254

SANOFI AVENTIS 263

VG LIFE SCIENCES INC. 278